+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Synthetic Biology Market 2019-2025

  • ID: 4871654
  • Report
  • October 2019
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Dec 31st 2021

FEATURED COMPANIES

  • Algenol
  • Autolus Therapeutics PLC
  • Desktop Genetics Ltd.
  • Editas Medicine, Inc.
  • GenScript Biotech Corp.
  • Merck KGaA
Global Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast 2019-2025.

The global synthetic biology market is expected to grow at a significant rate during the forecast period. Increasing research activities, innovative and advanced applications of synthetic biology, and increasing R&D investments in drug discovery and development are also supporting the growth of global synthetic biology market. However expensive research procedures, stringent regulatory requirements, and harmful effects of synthetic biology act as hindrance in the growth of the global market. The growing number of mergers and acquisitions is one of the latest trends observed in this market.

Synthetic biology is utilized in a number of applications including medical application, industrial application, food & agriculture, and environmental applications. In medical applications, synthetic biology is used in the development of diagnostic kits and vaccines and drug discovery. In environmental applications, it plays an important role in distinct chemicals immobilization, biotransformation, and pollution detection. Industrial application of synthetic biology includes the production of biofuel.

Geographically, the market is segmented into North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and Rest of the World (RoW). North America is expected to hold a significant share in the market owing to increasing R&D investment in the field of synthetic biology. Further, Asia-Pacific is expected to exhibit a considerable growth rate during the forecast period.

Moreover, the study of the report covers the competitive analysis of various players operating in the market. Some of the key players in the global synthetic biology market include Twist Bioscience Corp., Merck KGaA, GenScript Biotech Corp., Thermo Fisher Scientific Inc., Amyris Inc., Codexis Inc, Ginkgo Bioworks, and many others.

Research Methodology

The market study of the global synthetic biology is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report is intended for pharmaceutical companies, drug manufacturers, biotechnology companies, chemical and biofuel industry, academic and government research institutes, food and agriculture industries, potential investors and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:
1. Global Synthetic Biology Market Research and Analysis by Product.

2. Global Synthetic Biology Market Research and Analysis by Technology.

3. Global Synthetic Biology Market Research and Analysis by Application.

The Report Covers
  • Comprehensive research methodology of the global synthetic biology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global synthetic biology market.
  • Insights about market determinants which are stimulating the global synthetic biology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Algenol
  • Autolus Therapeutics PLC
  • Desktop Genetics Ltd.
  • Editas Medicine, Inc.
  • GenScript Biotech Corp.
  • Merck KGaA
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Twist Bioscience Corp.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Merck KGaA
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. GenScript Biotech Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Amyris Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Thermo Fisher Scientific Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Synthetic Biology Market by Product
5.1.1. Enabling Product
5.1.2. Core Product
5.1.3. Enabled Product
5.2. Global Synthetic Biology Market by Technology
5.2.1. Gene Synthesis & Sequencing
5.2.2. Genome Engineering
5.2.3. Bioinformatics
5.2.4. Others
5.3. Global Synthetic Biology Market by Application
5.3.1. Medical Application
5.3.2. Industrial Application
5.3.3. Food & Agriculture
5.3.4. Environmental Application

6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Algenol
7.2. Amyris Inc.
7.3. Autolus Therapeutics PLC
7.4. Butamax Advanced Biofuels LLC
7.5. Codexis Inc.
7.6. Desktop Genetics Ltd.
7.7. DNA TwoPointO Inc. (ATUM)
7.8. E. I. du Pont de Nemours and Co.
7.9. Editas Medicine, Inc.
7.10. Genewiz, Inc.
7.11. GenScript Biotech Corp.
7.12. Ginkgo Bioworks (The Organism Co)
7.13. Intellia Therapeutics, Inc.
7.14. Integrated DNA Technologies, Inc.
7.15. LGC Ltd.
7.16. Merck KGaA
7.17. OriGene Technologies, Inc.
7.18. Synthetic Genomics, Inc.
7.19. Synthorx, Inc.
7.20. Thermo Fisher Scientific, Inc.
7.21. Twist Bioscience Corp.
7.22. Vedanta Biosciences, Inc.
Note: Product cover images may vary from those shown
  • Algenol
  • Amyris Inc.
  • Autolus Therapeutics PLC
  • Butamax Advanced Biofuels LLC
  • Codexis Inc.
  • Desktop Genetics Ltd.
  • DNA TwoPointO Inc. (ATUM)
  • E. I. du Pont de Nemours and Co.
  • Editas Medicine, Inc.
  • Genewiz, Inc.
  • GenScript Biotech Corp.
  • Ginkgo Bioworks (The Organism Co)
  • Intellia Therapeutics, Inc.
  • Integrated DNA Technologies, Inc.
  • LGC Ltd.
  • Merck KGaA
  • OriGene Technologies, Inc.
  • Synthetic Genomics, Inc.
  • Synthorx, Inc.
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corp.
  • Vedanta Biosciences, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll